Antoni van Leeuwenhoek

Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer (2024) Benderska-Söder N, Ecke T, Kleinlein L, Roghmann F, Bismarck E, van Rhijn BW, Stenzl A, et al. Journal article, Review article Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases (2023) Figlioli G, Billaud A, Wang Q, Bolla MK, Dennis J, Lush M, Kvist A, et al. Journal article International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members (2023) Beijert IJ, Cheng L, Liedberg F, Plass K, Williamson SR, Gontero P, Ribal MJ, et al. Journal article Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival (2023) Lopes Cardozo JM, Andrulis IL, Bojesen SE, Dörk T, Eccles DM, Fasching P, Hooning MJ, et al. Journal article CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study (2023) Kang EY, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee CH, et al. Journal article FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women (2023) Figlioli G, Billaud A, Ahearn TU, Antonenkova NN, Becher H, Beckmann M, Behrens S, et al. Journal article Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-muscle-Invasive Bladder Cancer (2023) Ecke TH, Benderska-Söder N, Bismarck E, van Rhijn BW, Todenhöfer T, Schmitz-Dräger BJ Book chapter / Article in edited volumes Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy (2023) Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Shariat SF, Hippe K, Bertz S, et al. Journal article A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2 (2023) Zanti M, O'Mahony DG, Parsons MT, Li H, Dennis J, Aittomäkkiki K, Andrulis IL, et al. Journal article Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (Breast Cancer Research, (2022), 24, 1, (69), 10.1186/s13058-022-01567-3) (2022) Giardiello D, Hooning MJ, Hauptmann M, Keeman R, Heemskerk-Gerritsen BA, Becher H, Blomqvist C, et al. Journal article, Erratum